Dual Site-Dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Healthy Subjects

NCT ID: NCT03486808

Last Updated: 2019-09-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-28

Study Completion Date

2018-05-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate the effect of dual site-dual channel non-invasive brain stimulation for recovery of language and cognitive function in healthy. Simultaneous dual site-dual channel stimulation was applied by using two sets of transcranial direct current stimulation devices. All subjects will go through four conditions of transcranial direct current stimulation with for 30 minutes. Four conditions are 1) Dual stimulation: i) anodal stimulation on left inferior frontal cortex, ii) anodal stimulation on left dorsolateral prefrontal cortex. 2) IFG stimulation: anodal stimulation on left inferior frontal cortex; 3) DLPFC stimulation: anodal stimulation on left dorsolateral prefrontal cortex area. 4) sham stimulation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dual stimulation

i) anodal stimulation of left inferior frontal cortex ii) anodal stimulation on left dorsolateral prefrontal cortex

Group Type EXPERIMENTAL

IFG stimulation

Intervention Type DEVICE

stimulating left inferior frontal cortex with transcranial direct current stimulation for 30 minutes

DLPFC stimulation

Intervention Type DEVICE

stimulating left dorsolateral prefrontal cortex with transcranial direct current stimulation for 30 minutes

IFG stimulation

anodal stimulation of left inferior frontal cortex

Group Type ACTIVE_COMPARATOR

IFG stimulation

Intervention Type DEVICE

stimulating left inferior frontal cortex with transcranial direct current stimulation for 30 minutes

DLPFC stimulation

anodal stimulation on left dorsolateral prefrontal cortex

Group Type ACTIVE_COMPARATOR

DLPFC stimulation

Intervention Type DEVICE

stimulating left dorsolateral prefrontal cortex with transcranial direct current stimulation for 30 minutes

Sham stimulation

sham stimulation

Group Type SHAM_COMPARATOR

Sham stimulation

Intervention Type DEVICE

sham stimulation over both left inferior frontal cortex and dorsolateral prefrontal cortex

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IFG stimulation

stimulating left inferior frontal cortex with transcranial direct current stimulation for 30 minutes

Intervention Type DEVICE

DLPFC stimulation

stimulating left dorsolateral prefrontal cortex with transcranial direct current stimulation for 30 minutes

Intervention Type DEVICE

Sham stimulation

sham stimulation over both left inferior frontal cortex and dorsolateral prefrontal cortex

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy subjects with age over 19 years old

Exclusion Criteria

* history of disorders involving central nervous system
* patients with severe medical or psychiatric disease
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Samsung Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Samsung Medical Center

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-08-124-D

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.